Researchers at CU Anschutz Medical Campus identified key elements to improve diagnosis and treatment of coronary heart disease (CHD) in women, addressing the common misdiagnosis of heart attacks. The new guidelines provide recommendations to help clinicians better address sex-specific symptoms and treatments.
A team of researchers led by Dr. Ahmed discovered that two FDA-approved antibiotics can induce heart regeneration in mammals, showing promise for treating heart failure. The study found that the antibiotics improved cardiac output and reduced fibrotic scar tissue, suggesting a potential new therapy.
A study by Linköping University found that access to professional interpreters significantly increases Heart School attendance among foreign-born patients, leading to better treatment goals and outcomes. In contrast, Swedish-born patients showed no difference in participation rates with or without interpreters.
Researchers found beneficial effects of Sacubitril/Valsartan in reducing inflammation, cardiac fibrosis, and preventing arrhythmias post-MI. The drug has shown promise in mitigating these effects and promoting healthier scar formation.
A new study found that brief anger episodes can negatively impact blood vessel function, leading to increased risk of heart disease and stroke. The researchers investigated the effects of anger, sadness, and anxiety on blood vessel function and found that evoking an angered state led to blood vessel dysfunction.
Atrial fibrillation is more common and deadly among young Americans than previously believed, a new study found. The study of over 67,000 patients under 65 years old showed higher rates of hospitalization, stroke, heart attack, comorbidity, and mortality compared to their peers without Afib.
A randomized controlled trial confirms the routine use of Impella CP improves survival in patients who have had a heart attack with STEMI cardiogenic shock. The device reduces 180-day mortality by 12.7% compared to the control arm.
SourceAbiomed·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateApr 8, 2024
A new study published in the New England Journal of Medicine found that half of patients discharged from hospital after a heart attack are treated with beta-blockers unnecessarily. The study shows that these patients have suffered a small heart attack and have retained heart function afterwards.
A new study published in New England Journal of Medicine found that preventive angioplasty for heart attack patients does not improve prognosis. The research included 1542 patients and showed no difference between treatment groups in terms of new heart attacks or all-cause deaths.
A new study found that high-dose influenza vaccine significantly improved humoral response in patients with heart failure or prior myocardial infarction. Vaccination remains crucial in preventing influenza-related complications in high-risk populations.
A meta-analysis of 11 trials involving 78,607 patients found a 9% reduction in major adverse cardiovascular events (MACE) and a 14% reduction in cardiovascular death with SGLT2 inhibitors. The analysis showed consistent effects across patient groups and subgroups.
An experimental treatment further lowers triglyceride levels in patients with moderate to severe hypertriglyceridemia, reducing risk of heart attack and stroke by up to 53%.
Researchers found that withdrawing aspirin one month after PCI significantly reduced major and minor bleeding incidents by 55% compared to dual antiplatelet therapy. The study, ULTIMATE-DAPT, showed no increase in adverse ischemic events, suggesting continuing aspirin may cause harm without benefit.
A clinical trial with PeriCord, a new tissue engineering product derived from umbilical cord and pericardium stem cells, confirms its feasibility in repairing damaged heart tissues after a heart attack. The therapy has demonstrated excellent biocompatibility and anti-inflammatory properties.
A study led by Michigan Medicine found that around 10% of deaths following percutaneous coronary intervention are potentially preventable. Complications during procedures contributed to 20% of the nearly 1,200 deaths reported during the study period.
Two anti-inflammatory molecules, TGFβ1 and HpTGM, reduce the inflammatory response within the injured heart and scarring. Treatment with these proteins at the time of reperfusion reduces infarct size and mature scar size.
A new study suggests that most essential care for cardiovascular health happens in general primary care clinics, but many at high risk don't receive it. The study found that large percentages of people with major cardiovascular risk factors didn't see a primary care provider or cardiologist in the past year.
Studies at the University of Gothenburg found a clear shift in arterial disease risks in diabetes, with decreases in central organ diseases like heart attack and stroke, but increases in peripheral vessel complications. Closer monitoring of long-term blood sugar levels can reduce peripheral arterial disease risk by 30-50%.
According to the study, AEDs were only used in 13 of nearly 1,800 cases of out-of-hospital cardiac arrest, despite many incidents occurring within a four-minute walk of a public AED. Cardiac arrests outside of a hospital setting are usually fatal but administering CPR and using an AED greatly increases the chances of survival.
A large study found that drinking more than one drink per day can increase the risk of coronary heart disease, especially among young to middle-aged women. The risk was highest among those who engaged in binge drinking, with women facing a 68% higher risk compared to moderate drinkers.
A new study found that people with high genetic stress sensitivity are more likely to experience heart attacks during stressful periods, such as holidays and elections. Those who also have anxiety or depression are at even higher risk, with their likelihood tripled.
A study of partners and adult children of stroke survivors found higher risks of mental health conditions and self-harm or suicide. The findings highlight the potential consequences of stroke on family members, particularly partners.
Researchers have made progress in understanding atherosclerosis, identifying potential new approaches for early detection and therapy. The study found that TREM2 regulates the activity of macrophages, playing an important role in forming unstable plaques that increase heart attack and stroke risk.
Researchers found that Kupffer cells in liver respond to high cholesterol by removing excess, revealing the liver's role in regulating cholesterol levels. This discovery suggests atherosclerosis is a systemic disease affecting multiple organs.
Researchers at UVA Health System have discovered genetic clues that may help identify people at risk of cardiovascular disease, including atherosclerosis. The study identified 20 locations on chromosomes that influence protein production, shedding light on why smooth muscle cells sometimes are beneficial and sometimes harmful.
A new poll suggests that more than half of people aged 50-80 taking aspirin don't have cardiovascular disease, raising concerns about the effectiveness of routine aspirin use. Guidelines now focus on those with a history of cardiovascular issues or high risk due to personal health and family history.
A new study by the University of Illinois Chicago found that the average age for cardiac arrest outside the hospital fell from 64.7 to 62.7 among Chicagoans, with Black men experiencing the largest decline, leading to a 75% increase in lost years of life.
A new study published in Radiology found that coronary artery calcium scoring can identify patients with a low risk of heart attacks or strokes. Patients with a zero coronary artery calcium score showed very low risk of major adverse cardiovascular events, suggesting they may not require invasive coronary angiography.
Researchers developed a new catheter-based device combining FLIM with polarization-sensitive OCT to image atherosclerotic plaques. The hybrid approach provides unprecedented information on plaque morphology, microstructure, and biochemical composition.
A new study found that frequent cannabis use is associated with a higher risk of heart attack and stroke, even after controlling for tobacco use and other cardiovascular risk factors. The study analyzed data from over 430,000 adults in the US and found that smoking cannabis was significantly linked to cardiovascular risks.
A large observational study found that frequent cannabis smoking is associated with a significant increased risk of heart attack and stroke. Daily use was linked to a 25% increased likelihood of heart attack and a 42% increased likelihood of stroke, while less frequent use also showed an increased risk of cardiovascular events.
Using intravascular imaging to guide stent implantation significantly improves survival and reduces adverse cardiovascular events compared to angiography-guided PCI. The study found a 25% reduction in all-cause death, 45% reduction in cardiac death, and improved outcomes for patients with coronary artery disease.
A new study reveals that utilization of PCSK9 inhibitors is low among high-risk patients, despite extensive evidence documenting their role in LDL-C reduction and the prevention of heart attacks. The study found that insurance coverage rejection or abandonment leads to significantly more cardiovascular events within 12 months.
A recent study by Cleveland Clinic researchers discovered a connection between elevated niacin levels and an increased risk of heart disease. The study found that high levels of 4PY, a breakdown product from excess niacin, were strongly linked to the development of heart attacks and strokes.
A major new study reveals that heart attack survivors are at high risk of developing further serious health conditions, including heart failure, kidney disease, and depression. The research found that up to a third of patients developed heart or kidney failure, and 38% died within nine years.
A study published in Nature Cardiovascular Research reveals that a dynamic synergy between cell types facilitates cardiac renewal, challenging existing paradigms. Targeting the microenvironment rather than specific cell types is key to healing injured hearts.
Researchers at Uppsala University have developed a tool that uses standard blood test results to identify individuals at increased risk of having a heart attack within six months. The study analyzed data from 169,053 individuals and identified 90 molecules linked to a first heart attack.
Researchers discovered that reducing cholesterol levels in mice with advanced atherosclerosis leads to a decrease in the number of smooth muscle-derived cells causing plaque growth, while preserving stabilizing cell types. This finding opens up new opportunities for targeted therapies.
A recent study found that a stroke or combined with a neck artery tear significantly increases the risk of heart attack within a year. The researchers analyzed health data from over 800,000 adults and discovered that carotid or vertebral artery dissections without a stroke do not raise heart attack risk.
A recent survey found that 51% of Americans are unaware that heart disease is the leading cause of death in the US. This lack of knowledge can be deadly, with nearly half of adults having some form of cardiovascular disease.
A University of Queensland team has developed a spider venom molecule, Hi1a, that protects cells from heart attack and stroke damage. The drug candidate has passed critical benchmarks in preclinical tests, which indicate it could be an effective therapeutic with reduced side effects.
A study of 345 participants found COVID-19 linked to impaired brain health, with no greater impact than other serious illnesses. Long-term associations suggest brain health tied to overall disease severity and hospitalization.
Researchers at MMRI have developed a novel approach to minimize cardiac damage after a heart attack by targeting the spleen with histone deacetylase inhibitors. This targeting strategy results in a significant decrease in cardiac scar size and preservation of heart function, even after just one dose.
The Canadian Cardiovascular Society has updated its guidelines to no longer recommend routine daily aspirin use for primary prevention of heart attacks or death. However, daily aspirin may be considered for people with high risk factors for heart attack, such as diabetes, high cholesterol, and smoking. The new guidelines emphasize the ...
A recent study found that human induced pluripotent stem cell-derived cardiomyocytes interact negatively with myofibroblasts, leading to electrical instability and arrhythmogenic potential. Blocking Interleukin-6 signalling reduced these negative effects, suggesting a promising therapeutic strategy for safe regenerative treatments.
Black patients in integrated communities experience greatest benefits from PCI-CF openings, including a five times greater likelihood of receiving same-day PCI. Segregation is associated with poorer outcomes for racial minority groups.
Researchers at UVA Health System created an 'atlas of atherosclerosis' revealing critical processes that form harmful plaque buildup. The study provides unprecedented insights into atherosclerosis and its impact on coronary artery disease, heart attacks, and strokes.
A new study finds that consuming more oily fish like salmon and mackerel can lower the risk of cardiovascular diseases in people with a family history. The research suggests that these fatty acids EPA/DHA play a crucial role in mitigating this risk, especially for those with close relatives who have suffered from cardiovascular disease.
A novel prescription wristwatch uses photoplethysmography to detect atrial fibrillation with high accuracy, even in participants with darker skin tones. The Verily Study Watch bridges the gap between long-term monitoring and consumer devices, enabling clinicians to effectively use wearable data for Afib management.
Researchers discovered that adrenergic signals from the autonomic nervous system determine whether macrophages multiply and migrate into damaged heart tissue. This communication also plays a crucial role in regenerating heart muscle tissue.
A three-year intensive treatment strategy to lower systolic blood pressure below 120mmHg significantly reduced cardiovascular events, including heart attack, stroke, and death, compared to standard treatment. The study found that participants in the intensive group experienced fewer major vascular events and deaths over a two-year period.
A randomized controlled trial suggests that a more liberal approach to red blood cell transfusions for heart attack patients with anemia may benefit outcomes without significant risk. The study found no statistically significant difference between two transfusion strategies, but results suggest a possible benefit of liberal transfusions.
The ORBITA-2 trial found that stenting improves symptoms compared to a placebo procedure, providing evidence-based treatment for stable chest pain. The study suggests updating guidelines for stable coronary artery disease and offers patients and medical teams two treatment strategies with similar benefits.
A new study suggests that a PCSK9 inhibitor given every 1-3 months may effectively lower bad cholesterol levels in people with non-genetic hypercholesterolemia. The medication, recaticimab, showed similar effectiveness and safety as other PCSK9 inhibitors when administered less frequently.
A single infusion of CRISPR-based gene-editing therapy significantly reduced LDL cholesterol levels in people with heterozygous familial hypercholesterolemia, a condition that increases heart attack risk. The treatment has shown potential as a long-term or permanent option for high LDL-C control.
Researchers found that people with overweight or obesity who took semaglutide for over 3 years had a 20% lower risk of heart attack, stroke, or death from cardiovascular disease. The study showed significant weight loss and improved cardiovascular outcomes in adults without diabetes.
A liberal blood transfusion strategy reduced the risk of reoccurrence and improved survival rates in patients with heart attacks and anemia. The MINT trial found a 2.4% lower mortality or recurrent heart attack rate when using this approach.
A new study by Intermountain Health found that high levels of coronary calcium are common among people who have a heart attack but no known risk factors. The study suggests that scans to detect plaque buildup should be part of standard care for these patients, enabling early diagnosis and treatment.
A liberal blood transfusion strategy may reduce the risk of a reoccurrence of heart attacks in patients who have had a heart attack and have anemia, according to the Myocardium Infarction and Transfusion (MINT) trial. The study found a 2.4% lower mortality rate when patients received more blood.
A recent clinical trial found that semaglutide significantly reduced cardiovascular events in adults with overweight or obesity who do not have diabetes. The medication was shown to lower the risk of death from cardiovascular causes, nonfatal heart attacks, and strokes by 20% compared to placebo.